Russian Pharmaceutical Forum

On behalf of Adam Smith Conferences we would like to thank all the speakers, sponsors and delegates of the 17th international Russian Pharmaceutical Forum which took place on 17th - 19th May in St. Petersburg.
This year the Forum's extended 3 day programme, that included more than 90 presentations, generated a huge interest - over 550 people gathered at the Forum to listen to the presentations, to share opinions, and to discuss the current industry issues with the most respected and senior professionals in the industry.

Industry experts told us that the main factor affecting the success of any pharmaceutical company operating in Russia is its ability to adapt to market change. In a course of 3 days all forum delegated had a chance to hear from such companies as Novartis, Stada, Sanofi-aventis, Takeda, Nycomed, Hoffman la Roche, Dr Reddy's, ChemRar Hi-Tech Center, Johnson and Johnson, Protek, ROSTA, Pharmacy Chain 36.6, Rigla etc about their strategic priorities and current development plans:

All new topics and elements of programme that we have offered this year were well received by the Forum audience, in particular:

FOCUS SESSION: "Finding a New Competitive Edge and Driving Strategic Initiatives in the Pharmaceutical Business" (17th May) with the contribution from:

• VADIM VLASOV, Country President of Novartis Group Russia
• MILOS PETROVIC, General Manager of Hoffman la Roche, Russia
• DMITRIY EFIMOV, General Director of Nizhpharm and Vice President of STADA
• JOSTEIN DAVIDSEN, Senior Vice President of Nycomed Group and President of Nycomed Russia-CIS
• LEONID PARSHENKOV, General Manager of Abbott Products

INDUSTRY LEADERS' DEBATE (17th May) - interactive polling and discussion, featuring CEOs including:

• PATRICK AGHANIAN, Head of Eurasia Region, Sanofi-aventis
• JOSTEIN DAVIDSEN, Senior Vice President of Nycomed Group and President of Nycomed Russia-CIS
• SERGE SCOTTO, Vice President, Russia/CIS & CEE, Takeda
• DAVID PANIKASHVILI, President of Pharmaceutical Group ROSTA
• ANDREI GUSEV, CEO of Rigla
• VALERIA SOLOK, Chief Executive Officer of the Management Company "Pharmacy Chain 36.6"

TOPIC-SPECIFIC PARALLEL SESSIONS: "Establishing and developing pharmaceutical and bio industry clusters in Russia" with contributions from DEBBIE HART, President of BioNJ (New Jersey's Biotech Cluster), HORST DOMDEY, President of BioM Biotech Cluster (Munich Biotech Cluster).

An alternative one-day event "LEGAL AND REGULATORY ISSUES IN THE RUSSIAN PHARMACEUTICAL INDUSTRY" (19th May), parallel to SALES AND MARKETING day.

3 PANEL DISCUSSIONS
- Global and Regional Generics Growth - What does it mean for innovative pharmas, international generic companies and local producers?
- Health Financing Strategies and Provider Payment Mechanisms - Balancing state and market interests.
- Marketing to Physicians and Consumers - How to develop effective drug promotion strategies in the changing regulatory environment

and much, much more!

We are starting research for the 18th annual international Russian Pharmaceutical Forum that will take place in May 2012 and we will be delighted to welcome you all once again to our event!

For additional information regarding this event, or to find out how to participate as a delegate or a speaker, please contact: Jane Gelfand, Project Director at: +44 2033773290 or email: janeg@adamsmithconferences.com